---
title: "Incyte Corp. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287120734.md"
description: "Incyte Corp. (INCY) shares rose 1.55% to $97.08 on a strong trading day, outperforming some competitors. The S&P 500 Index increased by 1.08%, while the Dow Jones Industrial Average rose 1.31%. Incyte's stock remains 13.55% below its 52-week high of $112.29. Trading volume was 1.1 million, below the 50-day average of 1.5 million."
datetime: "2026-05-20T21:07:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287120734.md)
  - [en](https://longbridge.com/en/news/287120734.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287120734.md)
---

# Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. (INCY) advanced 1.55% to $97.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.08% to 7,432.97 and the Dow Jones Industrial Average rising 1.31% to 50,009.35.

This was the stock's second consecutive day of gains.

Incyte Corp. closed 13.55% below its 52-week high of $112.29, which the company reached on January 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc. (ALNY) rose 1.42% to $298.48, Bio-Techne Corp. (TECH) rose 2.71% to $46.70, and BioMarin Pharmaceutical Inc. (BMRN) rose 0.78% to $50.20.

Trading volume (1.1 M) remained 431,006 below its 50-day average volume of 1.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-20-26 1707ET

### Related Stocks

- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)
- [BMRN.US](https://longbridge.com/en/quote/BMRN.US.md)

## Related News & Research

- [Incyte And Genesis Expand Molecular Ai Collaboration To Accelerate Drug Discovery](https://longbridge.com/en/news/287067847.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Capricor publishes investor presentation on deramiocel Duchenne muscular dystrophy program](https://longbridge.com/en/news/287222906.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)